Cargando…
Identification of necroptosis-related gene TRAF5 as potential target of diagnosing atherosclerosis and assessing its stability
BACKGROUND: Atherosclerosis (AS) is a leading cause of morbidity and mortality in older patients and features progressive formation of plaques in vascular tissues. With the progression of atherosclerosis, plaque rupture may occur and cause stroke, myocardial infarction, etc. Different forms of cell...
Autores principales: | Peng, Zhanli, Wang, Kangjie, Wang, Shenming, Wu, Ridong, Yao, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276484/ https://www.ncbi.nlm.nih.gov/pubmed/37330462 http://dx.doi.org/10.1186/s12920-023-01573-0 |
Ejemplares similares
-
The Long Non-coding RNA AC148477.2 Is a Novel Therapeutic Target Associated With Vascular Smooth Muscle Cells Proliferation of Femoral Atherosclerosis
por: Wang, Kangjie, et al.
Publicado: (2022) -
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
por: Karunakaran, Denuja, et al.
Publicado: (2016) -
TRAF2 protects against cerebral ischemia-induced brain injury by suppressing necroptosis
por: Li, Jie, et al.
Publicado: (2019) -
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
por: Karl, I, et al.
Publicado: (2014) -
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
por: Karl, I, et al.
Publicado: (2014)